Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function

A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers

(2011) Peter W. Hunt et al.   PLoS One

Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points

(2011) K. K. Dietze et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy

(2010) Hong M. Moulton et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Regulatory T cells and breast cancer: implications for immunopathogenesis

(2010) Maria Angelica Ehara Watanabe et al.   CANCER AND METASTASIS REVIEWS

A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice

(2010) N. Casares et al.   JOURNAL OF IMMUNOLOGY

Antisense Phosphorodiamidate Morpholino Oligomers Targeted to an Essential Gene InhibitBurkholderia cepaciaComplex

(2010) David E. Greenberg et al.   JOURNAL OF INFECTIOUS DISEASES

Functional Analysis of FOXP3

(2009) Jane H. Buckner et al.   Annals of the New York Academy of Sciences

Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection

(2009) D. L. Swenson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cellular Uptake of Neutral Phosphorodiamidate Morpholino Oligomers

(2009) Patrick Iversen et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Antisense Targeting of cFLIP Sensitizes Activated T Cells to Undergo Apoptosis and Desensitizes Responses to Contact Dermatitis

(2009) Dan V. Mourich et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines

(2008) M. A. Morse et al.   BLOOD